164 related articles for article (PubMed ID: 22318991)
1. Major vault protein: a virus-induced host factor against viral replication through the induction of type-I interferon.
Liu S; Hao Q; Peng N; Yue X; Wang Y; Chen Y; Wu J; Zhu Y
Hepatology; 2012 Jul; 56(1):57-66. PubMed ID: 22318991
[TBL] [Abstract][Full Text] [Related]
2. Human hepatitis B virus surface and e antigens inhibit major vault protein signaling in interferon induction pathways.
Liu S; Peng N; Xie J; Hao Q; Zhang M; Zhang Y; Xia Z; Xu G; Zhao F; Wang Q; Han T; Zhu Y
J Hepatol; 2015 May; 62(5):1015-23. PubMed ID: 25481566
[TBL] [Abstract][Full Text] [Related]
3. The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals.
Steiner E; Holzmann K; Pirker C; Elbling L; Micksche M; Sutterlüty H; Berger W
J Cell Sci; 2006 Feb; 119(Pt 3):459-69. PubMed ID: 16418217
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes.
Larrea E; Riezu-Boj JI; Aldabe R; Guembe L; Echeverria I; Balasiddaiah A; Gastaminza P; Civeira MP; Sarobe P; Prieto J
Gut; 2014 Apr; 63(4):665-73. PubMed ID: 23787026
[TBL] [Abstract][Full Text] [Related]
5. Induction of high-molecular-weight (HMW) tumor necrosis factor(TNF) alpha by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-kappaB-dependent activation.
Hassan M; Selimovic D; Ghozlan H; Abdel-Kader O
Cell Signal; 2007 Feb; 19(2):301-11. PubMed ID: 16916598
[TBL] [Abstract][Full Text] [Related]
6. Inducible Major Vault Protein Plays a Pivotal Role in Double-Stranded RNA- or Virus-Induced Proinflammatory Response.
Peng N; Liu S; Xia Z; Ren S; Feng J; Jing M; Gao X; Wiemer EA; Zhu Y
J Immunol; 2016 Mar; 196(6):2753-66. PubMed ID: 26843330
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
[TBL] [Abstract][Full Text] [Related]
8. Set7 facilitates hepatitis C virus replication via enzymatic activity-dependent attenuation of the IFN-related pathway.
Han T; Wan Y; Wang J; Zhao P; Yuan Y; Wang L; She Y; Broering R; Lu M; Ye L; Zhu Y
J Immunol; 2015 Mar; 194(6):2757-68. PubMed ID: 25681344
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
[TBL] [Abstract][Full Text] [Related]
10. Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation.
Anggakusuma ; Romero-Brey I; Berger C; Colpitts CC; Boldanova T; Engelmann M; Todt D; Perin PM; Behrendt P; Vondran FW; Xu S; Goffinet C; Schang LM; Heim MH; Bartenschlager R; Pietschmann T; Steinmann E
Hepatology; 2015 Sep; 62(3):702-14. PubMed ID: 25999047
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis for the expression of major vault protein induced by hyperosmotic stress in SW620 human colon cancer cells.
Tajitsu Y; Ikeda R; Nishizawa Y; Mataki H; Che XF; Sumizawa T; Nitta M; Yamaguchi T; Yamamoto M; Tabata S; Akiyama S; Yamada K; Furukawa T; Takeda Y
Int J Mol Med; 2013 Sep; 32(3):703-8. PubMed ID: 23820674
[TBL] [Abstract][Full Text] [Related]
12. ME3738 enhances the effect of interferon and inhibits hepatitis C virus replication both in vitro and in vivo.
Abe H; Imamura M; Hiraga N; Tsuge M; Mitsui F; Kawaoka T; Takahashi S; Ochi H; Maekawa T; Hayes CN; Tateno C; Yoshizato K; Murakami S; Yamashita N; Matsuhira T; Asai K; Chayama K
J Hepatol; 2011 Jul; 55(1):11-8. PubMed ID: 21145867
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between Src and major vault protein in epidermal growth factor-dependent cell signalling.
Kim E; Lee S; Mian MF; Yun SU; Song M; Yi KS; Ryu SH; Suh PG
FEBS J; 2006 Feb; 273(4):793-804. PubMed ID: 16441665
[TBL] [Abstract][Full Text] [Related]
14. YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene.
Stein U; Bergmann S; Scheffer GL; Scheper RJ; Royer HD; Schlag PM; Walther W
Oncogene; 2005 May; 24(22):3606-18. PubMed ID: 15750632
[TBL] [Abstract][Full Text] [Related]
15. CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.
Rau SJ; Hildt E; Himmelsbach K; Thimme R; Wakita T; Blum HE; Fischer R
Hepatology; 2013 Jan; 57(1):23-36. PubMed ID: 22814930
[TBL] [Abstract][Full Text] [Related]
16. Identification of host genes involved in hepatitis C virus replication by small interfering RNA technology.
Ng TI; Mo H; Pilot-Matias T; He Y; Koev G; Krishnan P; Mondal R; Pithawalla R; He W; Dekhtyar T; Packer J; Schurdak M; Molla A
Hepatology; 2007 Jun; 45(6):1413-21. PubMed ID: 17518369
[TBL] [Abstract][Full Text] [Related]
17. Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication.
Itsui Y; Sakamoto N; Kurosaki M; Kanazawa N; Tanabe Y; Koyama T; Takeda Y; Nakagawa M; Kakinuma S; Sekine Y; Maekawa S; Enomoto N; Watanabe M
J Viral Hepat; 2006 Oct; 13(10):690-700. PubMed ID: 16970601
[TBL] [Abstract][Full Text] [Related]
18. Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation.
Helbig KJ; Ruszkiewicz A; Semendric L; Harley HA; McColl SR; Beard MR
Hepatology; 2004 May; 39(5):1220-9. PubMed ID: 15122750
[TBL] [Abstract][Full Text] [Related]
19. Expression and cellular distribution of major vault protein: a putative marker for pharmacoresistance in a rat model for temporal lobe epilepsy.
van Vliet EA; Aronica E; Redeker S; Gorter JA
Epilepsia; 2004 Dec; 45(12):1506-16. PubMed ID: 15571508
[TBL] [Abstract][Full Text] [Related]
20. Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression.
van Zon A; Mossink MH; Schoester M; Scheper RJ; Sonneveld P; Wiemer EA
Cancer Res; 2004 Jul; 64(14):4887-92. PubMed ID: 15256459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
